Variant report
Variant | esv3387143 |
---|---|
Chromosome Location | chr10:97469344-97469843 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566443154 | chr10:97469383-97469384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs28445650 | chr10:97469387-97469388 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs567319106 | chr10:97469394-97469395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543627104 | chr10:97469416-97469417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536459566 | chr10:97469424-97469425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6584014 | chr10:97469431-97469432 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs6584015 | chr10:97469435-97469436 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs544600345 | chr10:97469445-97469446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111624937 | chr10:97469512-97469513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375529737 | chr10:97469513-97469514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144332729 | chr10:97469520-97469521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558170624 | chr10:97469536-97469537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10670966 | chr10:97469538-97469539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs183102261 | chr10:97469561-97469562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142662663 | chr10:97469562-97469563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540543463 | chr10:97469568-97469569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186027687 | chr10:97469573-97469574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201235689 | chr10:97469647-97469648 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150514024 | chr10:97469649-97469650 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34037152 | chr10:97469653-97469654 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs118128004 | chr10:97469655-97469656 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527677453 | chr10:97469656-97469657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190930068 | chr10:97469689-97469690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551781974 | chr10:97469699-97469700 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565305844 | chr10:97469721-97469722 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182494007 | chr10:97469730-97469731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547336843 | chr10:97469753-97469754 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372802327 | chr10:97469806-97469807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7903181 | chr10:97469811-97469812 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Prostate cancer | 16573809 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21364760 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 24453001 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:97458800-97481400 | Weak transcription | Primary B cells from cord blood | blood |
2 | chr10:97469200-97471600 | Enhancers | Placenta | Placenta |
3 | chr10:97469400-97475600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
4 | chr10:97469600-97469800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr10:97469800-97470400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |